MedPath

Influence of Epidural Analgesia on Natural Killer Cell (NK) Activity After Colonic Cancer Surgery

Not Applicable
Conditions
Colonic Neoplasms
Interventions
Registration Number
NCT02326727
Lead Sponsor
Hillel Yaffe Medical Center
Brief Summary

Regional anesthesia may decrease the release of endogenous opioids, increase Natural Killer cell (NK) function and decrease development of metastasis. The recent analysis of the Cancer Registry has noted an improved 5-year survival in patients who received epidural analgesia during surgery for colorectal carcinoma.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients undergoing colonic cancer surgery
Exclusion Criteria
  • Patients with poor physical status Patients needed emergency surgery Coagulopathic disorders with international normalized ratio (INR) level more than 1.4 Thrombocytopenia with platelets count less 100000 per mcl Allergic reaction to local anesthetics in patient history Failure to performing the epidural analgesia from another cause Preoperative immunomodulating treatment Recent history of chemotherapy or radiation therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
General AnesthesiaPropofolPatients receiving general anesthesia with Fentanyl,Propofol, Isoflurane and Nitrous Oxide only during colonic cancer surgery
General AnesthesiaIsofluranePatients receiving general anesthesia with Fentanyl,Propofol, Isoflurane and Nitrous Oxide only during colonic cancer surgery
General AnesthesiaFentanylPatients receiving general anesthesia with Fentanyl,Propofol, Isoflurane and Nitrous Oxide only during colonic cancer surgery
Combined anesthesiaRopivacainePatients receiving general anesthesia and epidural analgesia with Ropivacaine during colonic cancer surgery
Combined anesthesiaIsofluranePatients receiving general anesthesia and epidural analgesia with Ropivacaine during colonic cancer surgery
Combined anesthesiaFentanylPatients receiving general anesthesia and epidural analgesia with Ropivacaine during colonic cancer surgery
Combined anesthesiaPropofolPatients receiving general anesthesia and epidural analgesia with Ropivacaine during colonic cancer surgery
General AnesthesiaNitrous OxidePatients receiving general anesthesia with Fentanyl,Propofol, Isoflurane and Nitrous Oxide only during colonic cancer surgery
Combined anesthesiaNitrous OxidePatients receiving general anesthesia and epidural analgesia with Ropivacaine during colonic cancer surgery
Primary Outcome Measures
NameTimeMethod
Count of live and dead target erythroleukemic cells72 hours

All clinical and laboratory parameters from blood samples taken before and after the operation will be compared between the two groups of patients. The nominal data comparison will be performed by ANOVA test, and the nonparametric data will be performed by Mann-Whitney test and interquartile ranges (IQR) for non-normally distributed data.

Plasma concentration of cytokines72 hours

All clinical and laboratory parameters from blood samples taken before and after the operation will be compared between the two groups of patients. The nominal data comparison will be performed by ANOVA test, and the nonparametric data will be performed by Mann-Whitney test and interquartile ranges (IQR) for non-normally distributed data.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hillel Yaffe Medical Center

🇮🇱

Hadera, Israel

© Copyright 2025. All Rights Reserved by MedPath